Synthesised sponge chemical shows promise for cancer

February 7, 2014

A promising compound for cancer treatment has been synthesised in a laboratory by an RMIT University researcher conducting PhD research.

Dr Dan Balan, from the School of Applied Sciences at RMIT, said 15-aza-Salicylihalamide A analogue had demonstrated potent activity against several leukaemia cell lines.

"Salicylihalamide A is an interesting natural marine product that has been isolated from a marine sponge of the genus Haliclona, collected from waters around Rottnest Island, 18 km off the coast of southern Western Australia," Dr Balan said.

Salicylihalamide A is cytotoxic – or a toxin which is known to destroy cells and which also provides a defence for the sea sponge.

"My goal was to synthesise the chemical in the laboratory in the form of a single aza-salicylihalamide A analogue molecule," he said.

The aza-salicylihalamide A analogue molecules were then exposed to NCI-60 leukaemia cell lines, and exhibited antiproliferating effects on the group of cells at highly diluted, or 'sub-molar,' concentrations.

"15-aza-Salicylihalamide A Analogue has proven to be very active against various types of , but it was clearly most active against HL-60, which is acute promyelocytic leukaemia," he said.

Other findings revealed it to be an inhibitor of vacuolar ATPase and proton pumps, frequently found in metastatic cancer – which are that have migrated through the bloodstream from more advanced tumours.

"The molecule was synthesised in a short molecular sequence that could be easily produced in very large volumes for drug production," Dr Balan said.

He explained there will be further research to investigate its effectiveness on different cancers, potentially leading to extensive drug development.

Explore further: Scientists find new drug target for hard-to-treat leukaemia

Related Stories

Scientists find new drug target for hard-to-treat leukaemia

March 30, 2012

(Medical Xpress) -- Cancer Research UK scientists have discovered a promising new approach to treat a type of myeloid leukaemia – a cancer with limited treatment options and relatively poor survival, according to research ...

Small molecule shows promise as anti-cancer therapy

January 13, 2014

Johns Hopkins scientists say a previously known but little studied chemical compound targets and shuts down a common cancer process. In studies of laboratory-grown human tumor cell lines, the drug disrupted tumor cell division ...

Leukemia: Mode of action of a targeted treatment clarified

January 15, 2014

The mechanism of senescence – or premature cell ageing – can have an anticancer effect. This new work, conducted by Hugues de Thé and his team (Paris Diderot University/ Inserm/ CNRS/ AP-HP), was published in Nature ...

Power lines don't raise risk of leukaemia in children

February 7, 2014

(Medical Xpress)—Children who live near overhead power lines in early life do not have a greater risk of developing childhood leukaemia, researchers from the Childhood Cancer Research Group at the University of Oxford have ...

Recommended for you

Researchers thwart cancer cells by triggering 'virus alert'

August 27, 2015

Working with human cancer cell lines and mice, researchers at the Johns Hopkins Kimmel Cancer Center and elsewhere have found a way to trigger a type of immune system "virus alert" that may one day boost cancer patients' ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.